Global Project Head, Solid Tumor Immuno-Oncology

Role Responsibilities: Drive worldwide clinical development and life cycle management for a late-stage solid tumor oncology immunotherapeutic compound. Lead the Global Product Team (GPT) to ensure optimal global compound development strategy in collaboration with the Global Brand Team (GBT). Own compound clinical development strategy and execution, including studies for regulatory purposes and budget planning. Lead cross-functional GPT planning and implementation of end-to-end compound strategy (translational, regulatory, drug manufacturing, safety, medical, commercial compound leads). Represent Clinical Development within the cross-functional GBT for commercial brand strategy. Present and discuss development strategy with internal stakeholders, external investigators/advisory boards, and worldwide regulatory authorities. Assess external business development opportunities in Hematopoietic Stem Cell Transplantation for Clinical Development; support implementation as applicable. Qualifications: MD or PhD. 7+ years of clinical development experience in Solid Tumor Oncology (biotech or pharmaceutical). Thorough understanding of global drug development and functional roles/responsibilities. Proven leadership of high-performing cross-functional clinical development teams. Experience with successful marketing authorization submissions. Excellent written and verbal communication skills. 20% domestic and international travel. Preferred Qualifications: Experience leading pivotal trials for regulatory approval in solid tumor oncology. Experience preparing regulatory submissions and negotiating with health authorities. Experience working in matrix environments and collaborating with commercial/medical functions in launch/post-launch settings. Ability to adapt to evolving data/regulatory/CI landscape. Benefits: Health and wellbeing benefits including high-quality healthcare, prevention/wellness programs, and at least 14 weeks’ gender-neutral parental leave. #J-18808-Ljbffr Scorpion Therapeutics